Covid-19

GSK’s COVID-related sales close to $2 billion, profit boost to wane in 2022

By
1 Mins read
94
0
Share
Reading Time: < 1 minute

GSK racked up 1.4 billion pounds ($1.9 billion) in COVID-related sales in 2021, largely for antibody drug sotrovimab, Read More

94
0
Share
Related posts
Covid-19

Covid vaccine boosters rejected by majority of Americans

By
1 Mins read
Reading Time: < 1 minute The majority of Americans intend to skip their next Covid-19 booster vaccine, a survey has found. Read More
Covid-19

Rise in Covid-19 hospital admissions as health chiefs warn of ‘winter threats’

By
1 Mins read
Reading Time: < 1 minute Covid-19 hospital admissions in England are continuing to rise, but remain at low levels, as health experts urged eligible people not to…
Covid-19

‘Beyond reasonable doubt’ Covid pandemic originated at Wuhan market stall

By
1 Mins read
Reading Time: < 1 minute It is beyond “reasonable doubt” that the Covid-19 pandemic originated in a Chinese animal market, a new scientific study has found.  Read More
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.